# East New Britain Province Monitoring & Evaluation

> **NCT04124250** · — · COMPLETED · sponsor: **University Hospitals Cleveland Medical Center** · enrollment: 12930 (actual)

## Conditions studied

- Lymphatic Filariasis Elimination by Mass Drug Administration
- Monitoring and Evaluation of Mass Drug Administration for Lymphatic Filariasis
- Acceptability of Mass Drug Administration for Lymphatic Filariasis

## Interventions

- **OTHER:** Observational

## Key facts

- **NCT ID:** NCT04124250
- **Lead sponsor:** University Hospitals Cleveland Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-17
- **Primary completion:** 2024-01-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 12930 (ACTUAL)
- **Last updated:** 2024-11-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04124250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04124250, "East New Britain Province Monitoring & Evaluation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04124250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*